Patent details

Basic Information

Publication number:

EP3121271

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP161855531

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME

French Title of Invention:

ANTIDOTES POUR INHIBITEURS DU FACTEUR XA ET PROCÉDÉS D'UTILISATION ASSOCIES

German Title of Invention:

GEGENMITTEL FÜR FAKTOR-XA-HEMMER UND VERFAHREN ZUR VERWENDUNG DAVON

SPC Number:

Dates

Filing date:

29/03/2010

Grant date:

24/07/2019

EP Publication Date:

25/01/2017

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/07/2019

EP B1 Publication Date:

24/07/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/03/2020

Expiration date:

29/03/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/07/2019

 

 

Name:

Portola Pharmaceuticals, Inc.

Address:

270 East Grand Avenue, Suite 22, San Francisco, CA 94080, United States (US)

Inventor

1

Name:

LU, Genmin

Address:

United States (US)

2

Name:

SINHA, Uma

Address:

United States (US)

3

Name:

CONLEY, Pamela B.

Address:

United States (US)

Priority

Priority Number:

164886 P

Priority Date:

30/03/2009

Priority Country:

United States (US)

Classification

IPC classification:

A61P 7/04; C12N 9/64;

Publication

European Patent Bulletin

Issue number:

201930

Publication date:

24/07/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages